Literature DB >> 25583525

Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.

Emilie Camberlein1, Jonathan M Cohen2, Ricardo José1, Catherine J Hyams1, Robin Callard3, Suneeta Chimalapati1, Jose Yuste4, Lindsey A Edwards1, Helina Marshall1, Nico van Rooijen5, Mahdad Noursadeghi6, Jeremy S Brown7.   

Abstract

Although the importance of alveolar macrophages for host immunity during early Streptococcus pneumoniae lung infection is well established, the contribution and relative importance of other innate immunity mechanisms and of bacterial factors are less clear. We have used a murine model of S. pneumoniae early lung infection with wild-type, unencapsulated, and para-amino benzoic acid auxotroph mutant TIGR4 strains to assess the effects of inoculum size, bacterial replication, capsule, and alveolar macrophage-dependent and -independent clearance mechanisms on bacterial persistence within the lungs. Alveolar macrophage-dependent and -independent (calculated indirectly) clearance half-lives and bacterial replication doubling times were estimated using a mathematical model. In this model, after infection with a high-dose inoculum of encapsulated S. pneumoniae, alveolar macrophage-independent clearance mechanisms were dominant, with a clearance half-life of 24 min compared to 135 min for alveolar macrophage-dependent clearance. In addition, after a high-dose inoculum, successful lung infection required rapid bacterial replication, with an estimated S. pneumoniae doubling time of 16 min. The capsule had wide effects on early lung clearance mechanisms, with reduced half-lives of 14 min for alveolar macrophage-independent and 31 min for alveolar macrophage-dependent clearance of unencapsulated bacteria. In contrast, with a lower-dose inoculum, the bacterial doubling time increased to 56 min and the S. pneumoniae alveolar macrophage-dependent clearance half-life improved to 42 min and was largely unaffected by the capsule. These data demonstrate the large effects of bacterial factors (inoculum size, the capsule, and rapid replication) and alveolar macrophage-independent clearance mechanisms during early lung infection with S. pneumoniae.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25583525      PMCID: PMC4333471          DOI: 10.1128/IAI.02788-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.

Authors:  Thomas Bewick; Carmen Sheppard; Sonia Greenwood; Mary Slack; Caroline Trotter; Robert George; Wei Shen Lim
Journal:  Thorax       Date:  2012-02-28       Impact factor: 9.139

2.  Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.

Authors:  Hazem E Ghoneim; Paul G Thomas; Jonathan A McCullers
Journal:  J Immunol       Date:  2013-06-26       Impact factor: 5.422

3.  Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.

Authors:  Suneeta Chimalapati; Jonathan Cohen; Emilie Camberlein; Claire Durmort; Helen Baxendale; Corné de Vogel; Alex van Belkum; Jeremy S Brown
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

4.  Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.

Authors:  Keer Sun; Yan Gan; Dennis W Metzger
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

5.  Mathematical model of a three-stage innate immune response to a pneumococcal lung infection.

Authors:  Amber M Smith; Jonathan A McCullers; Frederick R Adler
Journal:  J Theor Biol       Date:  2011-02-12       Impact factor: 2.691

6.  Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.

Authors:  John C Phipps; David M Aronoff; Jeffrey L Curtis; Deepti Goel; Edmund O'Brien; Peter Mancuso
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

7.  Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.

Authors:  Catherine Hyams; Jose Yuste; Katie Bax; Emilie Camberlein; Jeffrey N Weiser; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

8.  Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation.

Authors:  Jonathan M Cohen; Suneeta Khandavilli; Emilie Camberlein; Catherine Hyams; Helen E Baxendale; Jeremy S Brown
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

9.  Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence.

Authors:  Carlos J Sanchez; Cecilia A Hinojosa; Pooja Shivshankar; Catherine Hyams; Emilie Camberlein; Jeremy S Brown; Carlos J Orihuela
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses.

Authors:  R Wilson; J M Cohen; R J Jose; C de Vogel; H Baxendale; J S Brown
Journal:  Mucosal Immunol       Date:  2014-10-29       Impact factor: 7.313

View more
  13 in total

1.  Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.

Authors:  Niharika Sharma-Chawla; Vicky Sender; Olivia Kershaw; Achim D Gruber; Julia Volckmar; Birgitta Henriques-Normark; Sabine Stegemann-Koniszewski; Dunja Bruder
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

2.  Alveolar macrophage development in mice requires L-plastin for cellular localization in alveoli.

Authors:  Elizabeth M Todd; Julie Y Zhou; Taylor P Szasz; Lauren E Deady; June A D'Angelo; Matthew D Cheung; Alfred H J Kim; Sharon Celeste Morley
Journal:  Blood       Date:  2016-10-06       Impact factor: 22.113

3.  Potential role of the antimicrobial peptide Tachyplesin III against multidrug-resistant P. aeruginosa and A. baumannii coinfection in an animal model.

Authors:  Jialong Qi; Ruiyu Gao; Cunbao Liu; Bin Shan; Fulan Gao; Jinrong He; Mingcui Yuan; Hanghang Xie; Shumei Jin; Yanbing Ma
Journal:  Infect Drug Resist       Date:  2019-09-23       Impact factor: 4.003

4.  A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza.

Authors:  Amber M Smith; Amanda P Smith
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

5.  Effects of Coal Fly Ash Particulate Matter on the Antimicrobial Activity of Airway Surface Liquid.

Authors:  Luis G Vargas Buonfiglio; Imali A Mudunkotuwa; Mahmoud H Abou Alaiwa; Oriana G Vanegas Calderón; Jennifer A Borcherding; Alicia K Gerke; Joseph Zabner; Vicki H Grassian; Alejandro P Comellas
Journal:  Environ Health Perspect       Date:  2017-07-05       Impact factor: 9.031

6.  Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.

Authors:  Robert Wilson; Jonathan M Cohen; Mark Reglinski; Ricardo J Jose; Win Yan Chan; Helina Marshall; Corné de Vogel; Stephen Gordon; David Goldblatt; Fernanda C Petersen; Helen Baxendale; Jeremy S Brown
Journal:  PLoS Pathog       Date:  2017-01-30       Impact factor: 6.823

Review 7.  Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling.

Authors:  Amber M Smith
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

8.  Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae.

Authors:  Freya Cools; Eveline Torfs; Juliana Aizawa; Bieke Vanhoutte; Louis Maes; Guy Caljon; Peter Delputte; Davie Cappoen; Paul Cos
Journal:  Front Microbiol       Date:  2019-02-21       Impact factor: 5.640

9.  Impaired expression of CXCL5 and matrix metalloproteinases in the lungs of mice with high susceptibility to Streptococcus pneumoniae infection.

Authors:  Rubia I Mancuso; Eliane N Miyaji; Cristiane C F Silva; Fernanda V Portaro; Alessandra Soares-Schanoski; Orlando G Ribeiro; Maria Leonor S Oliveira
Journal:  Immun Inflamm Dis       Date:  2017-11-09

Review 10.  Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes.

Authors:  Jens Markus Borghardt; Charlotte Kloft; Ashish Sharma
Journal:  Can Respir J       Date:  2018-06-19       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.